Leukemia Inhibitory Factor (LIF) Peptide
LIF
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940098
Quick Overview for Leukemia Inhibitory Factor (LIF) Peptide (ABIN940098)
Target
LIF
(Leukemia Inhibitory Factor (LIF))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- KVLAAGVVPL LLVLHWKHGA GSPLPITPVN ATCAIRHPCH NNLMNQIRSQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody,
Alternative Names: LIF control peptide, LIF antibody Blocking Peptide, Anti-LIF Blocking Peptide, Leukemia Inhibitory Factor Blocking Peptide, Cholinergic Differentiation Factor Blocking Peptide, CDF Blocking Peptide, D-FACTOR Blocking Peptide, HILDA Blocking Peptide
-
-
Leukemia Inhibitory Factor (LIF) peptide (Ovalbumin)
LIF Reactivity: Pig Host: Synthetic WB, Imm, SDS
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Background
- LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface.
-
Molecular Weight
- 22 kDa
Target
-
You are here:
